Unusual Options Volume Report: 3 Stocks Moving After Earnings

DraftKings (DKNG) fell 29% after missing earnings estimates, while TransMedics (TMDX) rose 20.3% on better-than-expected results. Omada Health (OMDA) dropped 19.8% despite beating estimates. All three saw unusual options activity.

Original reporting
Published Nov 6, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Unusual Options Volume Report: 3 Stocks Moving After Earnings — source image
Decision brief

The 30-second read

$DKNGBearishHigh
01

Why it matters

Earnings beats and misses are driving immediate price swings and option activity, creating short‑term trading opportunities.

02

Market read

First‑time earnings disclosures with sizable price moves create actionable trading signals for each ticker.

03

What to watch

OMDA's revenue growth may signal a turnaround that the market is undervaluing in the immediate sell‑off.

Relevance 7/10Novelty 8/10Timing: after‑hours reaction

Background

The article highlights unusual options volume and sharp price moves for three companies following their quarterly earnings releases.

Company-level read

Ticker impact

$DKNGBearishHigh confidence
Context

DKNG reported a wider-than-expected Q3 loss and its stock plunged 29% after earnings.

Expected impact

likely further downside as market prices in the earnings miss

Evidence & confidence

The 29% drop and negative net option delta indicate bearish sentiment and potential continued sell pressure.

$TMDXBullishHigh confidence
Context

TMDX posted adjusted earnings and revenue that beat expectations, sending the stock up 20.3% after earnings.

Expected impact

likely further upside as investors digest the beat and strong net option delta

Evidence & confidence

The 20% rally and positive net option delta suggest continued buying interest.

$OMDABearishHigh confidence
Context

OMDA delivered better‑than‑expected Q3 results but its stock fell 19.8% despite the beat.

Expected impact

likely continued decline as bearish sentiment outweighs the earnings beat

Evidence & confidence

The large price drop and negative net option delta indicate sellers dominate the reaction.

Market effects

The earnings surprises may shift sentiment in the sports betting, medical tech, and digital health sectors.

U.S. equity markets could see volatility in related subsectors during after‑hours trading.

Limited to U.S. listed companies; no broader macro impact.

Counterpoint

DKNG's heavy investment in prediction markets could be a long‑term growth catalyst despite the short‑term miss.

Key entities

  • DraftKings Inc

    Sports betting operator reporting a Q3 loss.

  • TransMedics Group Inc

    Medical technology firm reporting earnings beat.

  • Omada Health Inc

    Digital health company reporting earnings beat but stock decline.

Related articles

$DKNGMedAI 8/10

DraftKings (DKNG) Q3 2026 Earnings Call Transcript

DraftKings (DKNG) raised its 2026 adjusted EBITDA guidance to $650M-$700M, citing strong performance in its predictions business. The company expects 17% revenue growth at the midpoint, with predictions revenue contributing $700M. Core business adjusted EBITDA is projected to reach $1.2B in 2026, with further expansion in 2027. The company's predictions business is performing well, with high customer retention and engagement.

$DKNGHighAI 9/10

DraftKings Stock Plunges 20% Amid Prediction Markets Bet

DraftKings stock fell 30% after Q3 earnings. Revenue was $1.33B, below expectations. The company cut 2026 EBITDA guidance to $175M–$275M, down from $700M–$900M, due to $700M investment in prediction markets. Management predicts 2027 prediction revenue of $650M–$750M, with legal challenges and customer acquisition costs as key risks.

$DKNGHighAI 8/10

What DraftKings (DKNG) Said on Its Q3 Earnings Call

DraftKings (DKNG) provided 2027 revenue guidance of $7.35B-$7.75B and adjusted EBITDA of $800M-$1B. Predictions revenue is expected to reach $650M-$750M, with core adjusted EBITDA of $1.15B-$1.25B. The company sees regulatory risks but anticipates Predictions to boost EBITDA in 2028. Q3 sportsbook net revenue grew 36% YoY, while iGaming customer acquisition rose 76% YoY.

$DKNGHigh

Midterms Could Alter DraftKings' Prediction Market Plans

DraftKings CEO Jason Robins indicated the company may adjust prediction-market spending based on midterm election results, potentially targeting states like Texas, Minnesota, and Georgia. The company raised its 2026 prediction-market adjusted EBITDA investment forecast to $650M-$700M and reduced its 2023 overall adjusted EBITDA guidance to $175M-$275M, causing a 25% stock drop. DraftKings estimates 99% of its prediction-market volume comes from states where sports betting is illegal.